The Asia Pacific Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Pacific Examiner.

Press releases published on March 3, 2026

Mar. 3, 2026

Propanc Biopharma’s Lead Asset PRP Shows >85% Tumor Growth Inhibition in Preclinical Pancreatic Models

Indeterminate GlobeNewswire

Mar. 3, 2026

Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call

Indeterminate GlobeNewswire

Mar. 3, 2026

Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference

Indeterminate GlobeNewswire

Mar. 3, 2026

rYojbaba Announces $3.2 Million Comprehensive Global Labor Support and Union Infrastructure Development Agreement with International Labor Union

Indeterminate GlobeNewswire

Mar. 3, 2026

Global Mofy Recognized in the 2025 Chinese Listed Companies Brand 500

Indeterminate GlobeNewswire

Mar. 3, 2026

Founder Group Limited Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

Indeterminate GlobeNewswire

Mar. 3, 2026

Kyverna Therapeutics to Participate in Upcoming March Investor Conferences

Indeterminate GlobeNewswire

Mar. 3, 2026

T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors

Indeterminate GlobeNewswire

Mar. 3, 2026

Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT

Indeterminate GlobeNewswire

Mar. 3, 2026

Bookipi Survey Shows Small Businesses Embracing AI BUT, Complexity, Not Cost, Slows Workflow Adoption

Indeterminate GlobeNewswire

Mar. 3, 2026

Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026

Indeterminate GlobeNewswire

Mar. 3, 2026

Xunlei Limited Announces Entry into Definitive Agreements for Disposition of Majority Equity Interest in Shenzhen Onething

Indeterminate GlobeNewswire

Mar. 3, 2026

Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million

Indeterminate GlobeNewswire

Mar. 3, 2026

FBS Global Regains Full Nasdaq Compliance; Minimum Bid Price Matter Resolved

Indeterminate GlobeNewswire

Mar. 3, 2026

Uni-Fuels Accelerates Global Growth with Nationwide Bunkering in Thailand

Indeterminate GlobeNewswire

Mar. 3, 2026

Azurite Medical & Wellness Launches Comprehensive Full Facelift Package with Internationally Accredited ISAPS Surgeons

Indeterminate EIN Presswire

Mar. 3, 2026

Antalpha Reports Fourth Quarter and Full Year 2025 Results

Indeterminate GlobeNewswire

Mar. 3, 2026

Samfine Secures Domestic Printing Permit, Expands Access to PRC Publication Market

Indeterminate GlobeNewswire

Mar. 3, 2026

Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference

Indeterminate GlobeNewswire

Mar. 3, 2026

DEEP SEA MINERALS CORP. SIGNALS INTENT TO PROCEED WITH LICENSE APPLICATION IN ACCORDANCE WITH U.S. NOAA PROCESS

Indeterminate GlobeNewswire